Company

iFyber Team

Meet the Team Behind Our Commitment to Excellence and Innovation in Product Development.

At its core, iFyber was founded on the principle of creatively solving problems at the interface between chemistry, biology, and materials science, and our team of scientists reflects this mission.

With varied models of engagement and a multidisciplinary team, including microbiologists, biomedical engineers, analytical chemists, and synthetic chemists, with commercial and regulatory team members, we can meet the diverse service needs of companies of all sizes across several industries.

Our team’s mission is to help our clients turn their technology into market-ready products. At all stages of product development, from exploratory research for conceptual evaluation to comparative marketing studies highlighting the benefits of your technology, we have the intended clinical use and potential regulatory pathway in mind.

Our scientists are involved in every project step – from initial conversations and proposals to data analysis and reporting.
We strive to build a culture of collaboration that fosters innovative and creative problem-solving through the open exchange of information and ideas.
The strong relationships we build are paramount to our success in delivering high-quality service and fast, reliable results.
Over 50% of our technical team holds advanced degrees (Ph.D., M.S.), demonstrating our commitment to hiring highly trained and skilled scientists.

Contact an iFyber scientist today to design the appropriate studies for your product or application.

Leadership

Greg Mouchka, President of iFyber

Greg Mouchka

President

Greg joined iFyber as president in 2016 and is responsible for providing strategic leadership to the organization and creating and implementing processes supporting our core mission. He brings over 15 years of industry experience working with a range of companies, from medical device start-ups to mature established organizations. With a strong cross-functional background and understanding of the product development process, Greg has developed and executed the business and development plans of large multi-stakeholder projects for both medical devices and applied market technologies.

Aaron Strickland, Vice President of Research and Development

Aaron Strickland, Ph.D.

Vice President of Research and Development

Aaron is the co-founder of iFyber and the technical lead for the organization. He brings over 20 years of research experience across diverse fields, including synthetic chemistry, analytical chemistry, microbiology and molecular biology, and nanotechnology.

Aaron leads multidisciplinary teams as the principle investigator and study director on both corporate-funded projects and federal grants and contracts for the National Science Foundation, the National Institutes of Health, the US Navy, the US Army, the US Air Force, and DARPA.

As technical lead, he plays a key business development role by facilitating exploratory and collaborative project conversations with potential and current clients.

During method development efforts and study execution, Aaron is the primary resource for creative problem-solving and experimental design when overcoming methodological or technical hurdles. In addition, he chairs the iFyber Scientific Advisory Board and SABs for corporate customers.

Aaron received his Ph.D. in chemistry from the University of Wyoming and performed postdoctoral work in microbiology and biotechnology at Cornell University.

Kelly Cycon, iFyber

Kelly Cycon, BS, Ph.D.

Vice President (VP)

Kelly joined iFyber in February of 2023 as a Vice President. Previously, she worked in the infectious disease medical device industry at ZeptoMetrix as Director of Virology for over 14 years. As Director, Kelly continually sourced viruses and developed novel product lines to expand the virology product portfolio and generate additional business.

She works closely with customers to provide viruses required for the analytical testing of diagnostic assays and designed custom studies to address various clients’ needs. As a VP at iFyber, Kelly continues to interface with customers, manage technical programs, and oversee the regulatory operations.

Kelly received her Bachelor's degree in Biotechnology from the Rochester Institute of Technology, and her Ph.D. in Immunology from the University at Buffalo.

Tony Eisenhut, CEO of iFyber

Tony Eisenhut, BS

Chief Operations and Financial Officer (COO/CFO)

Tony Eisenhut is the COO and CFO of iFyber, bringing over three decades of experience in business building across diverse industries, including chemicals, CPG, CRO, and medical devices. As a seasoned entrepreneur and business leader, Tony's expertise lies in market-centric assessment and analysis, a fundamental tenet of his daily efforts for over twenty years.

His professional focus has been the creation and growth of businesses launched from university research in the natural sciences. Tony has launched 8 university-derived startups. His strong belief that disruptive startup companies can only flourish if they are operationally excellent and exist in an ecosystem that equally amplifies their technical innovation and understanding of existing market requirements has led to the successful exit of six companies.

Tony currently sits on the boards of several companies, including iFyber. He has also served as an advisor to New York State's NextGen program, as a board member of the Center for Life Science Enterprise, and spent six years on the Board of Directors of Cayuga Medical Center.

Tony earned his B.S. degree from Cornell University.

Explore Our Expertise

If you’re interested in a position with iFyber, please visit our careers page for more information.